CLINICAL_TRIALS
trial_result
· 2025-05-30
Clinical Trial Update: Spatz3 Adjustable Balloon System® (Spatz3) Post Approval Study
Summary
A post-approval study evaluating the Spatz3 Adjustable Balloon System for obesity has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Spatz FGIA, Inc | Conditions: Obesity | Status: COMPLETED